- Home
- BZUN vs GNFT Comparison
BZUN vs GNFT Comparison
Compare BZUN & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- GNFT
- Stock Information
- Founded
- BZUN 2007
- GNFT 1999
- Country
- BZUN China
- GNFT France
- Employees
- BZUN N/A
- GNFT N/A
- Industry
- BZUN Catalog/Specialty Distribution
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BZUN Consumer Discretionary
- GNFT Health Care
- Exchange
- BZUN Nasdaq
- GNFT Nasdaq
- Market Cap
- BZUN 188.7M
- GNFT 172.2M
- IPO Year
- BZUN N/A
- GNFT 2019
- Fundamental
- Price
- BZUN $2.86
- GNFT $3.46
- Analyst Decision
- BZUN Strong Buy
- GNFT Strong Buy
- Analyst Count
- BZUN 3
- GNFT 1
- Target Price
- BZUN $3.20
- GNFT $13.00
- AVG Volume (30 Days)
- BZUN 879.1K
- GNFT 6.4K
- Earning Date
- BZUN 11-21-2024
- GNFT 09-19-2024
- Dividend Yield
- BZUN N/A
- GNFT N/A
- EPS Growth
- BZUN N/A
- GNFT N/A
- EPS
- BZUN N/A
- GNFT 0.47
- Revenue
- BZUN $1,312,737,613.00
- GNFT $86,225,222.00
- Revenue This Year
- BZUN $8.16
- GNFT $145.20
- Revenue Next Year
- BZUN $4.71
- GNFT N/A
- P/E Ratio
- BZUN N/A
- GNFT $7.17
- Revenue Growth
- BZUN 7.26
- GNFT 175.45
- 52 Week Low
- BZUN $1.90
- GNFT $3.31
- 52 Week High
- BZUN $4.38
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- BZUN 49.93
- GNFT 30.39
- Support Level
- BZUN $2.67
- GNFT $3.44
- Resistance Level
- BZUN $3.09
- GNFT $3.90
- Average True Range (ATR)
- BZUN 0.17
- GNFT 0.14
- MACD
- BZUN -0.02
- GNFT 0.01
- Stochastic Oscillator
- BZUN 30.99
- GNFT 18.64
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.